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Objective: The aim of this study was to investigate uni­
dimensionality and differential item functioning of the SF­
36 physical functioning scale (PF10) in patients with various 
neurological disorders. 
Patients: Patients post­stroke (n = 198), with multiple sclero­
sis (n = 151) and amyotrophic lateral sclerosis (n = 193) 
participated. 
Methods: Unidimensionality of the PF10 within the patient 
groups was investigated by performing a separate Rasch 
analysis for each group. Differential item functioning was 
investigated in a pooled Rasch analysis of the 3 groups. 
Results: Within each group, all items fitted the Rasch mo­
del, except the “bathing/dressing” item in the amyotrophic 
lateral sclerosis group. The pooled analysis showed inade­
quate fit to the Rasch model for one item (“walking seve­
ral hundred metres”). Of the other 9 fitting items, 5 showed 
differential item functioning for stroke vs multiple sclerosis 
and amyotrophic lateral sclerosis, while no differential item 
functioning was found between multiple sclerosis and amyo­
trophic lateral sclerosis. 
Conclusion: All items of the PF10, except one for the amyo­
trophic lateral sclerosis group, form a unidimensional scale, 
supporting the use of a sum score as a measure of physical func­
tioning within these diagnostic groups. When comparing the 
data of patients after stroke, with that of patients with multip­
le sclerosis and/or amyotrophic lateral sclerosis patients, ad­
justments for differential item functioning are required.
Key words: amyotrophic lateral sclerosis, cross-diagnostic va-
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INTRODUCTION
Describing and examining the outcomes of rehabilitation treat-
ment is becoming increasingly important for evidence-based 
practice and for policy-makers. Adequate measurement instru-
ments to assess disability are therefore essential. The 36-item 
Short Form health survey of the Medical Outcome Study (SF-
36) is a generic measurement instrument that was developed to 
measure health-related quality of life in patients and healthy 
persons. It consists of 8 sub-scales that are often used separately 
as outcome measures of various aspects of health-related qua-
lity of life (1–4). The 10-item Physical Functioning sub-scale 
(PF10) is of specific interest for application in rehabilitation 
because of its focus on physical disability (5), measured at the 
level of activity according to the International Classification of 
Functioning (6). It is important that instruments that are used 
to measure (changes in) physical disability in different patient 
groups fulfil several psychometric requirements (7). Among 
those, it is important that all individual items of multi-item 
scales measure the same underlying construct on a hierarchical 
scale (show unidimensionality). This is particularly important 
when ordinal item ratings are summed up to yield a total score 
(8, 9). If the items form a hierarchical measurement scale, less 
disabled subjects are more likely to pass difficult items than 
more disabled subjects, and vice versa. When a measurement 
instrument fulfils this requirement, unidimensionality of the 
scale is supported, and the calculation of total sum scores is 
allowed. These characteristics should be tested in each patient 
group before the instrument is used.
In rehabilitation, generic measures are frequently used for 
pooling or comparing the data of different patient groups (10). 
In this case, the items should function the same across all the 
patient groups. When items do not function similarly across 
groups, this is called differential item functioning (DIF). 
Although DIF is being increasingly investigated for the cross-
cultural validation of (translations of) questionnaires used 
in rehabilitation (11–13), very little attention has been paid 
to disease-specific characteristics as a cause of DIF (cross- 
diagnostic validity). The Rasch measurement model is a met-
hod that can be used to investigate unidimensionality and DIF. 
In Rasch analysis, ordinal scores are converted into interval 
measures of person ability and item difficulty along a common 
measurement continuum (14). This makes it possible to make 
a detailed investigation of the unidimensionality of a scale, as 
well as DIF across groups (13, 15). 
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A few studies have investigated the unidimensionality of the 
PF10 (5, 16–19) and DIF across groups of patients (5, 17, 19) 
or countries (18). In some of these studies it was found that 
the items represent a unidimensional construct in most patient 
groups and in the general populations of several European 
countries (18), and that the item hierarchy was reproducible 
across different patient groups (5) and countries (18). In cont-
rast, other studies concluded that the items of the PF10 do not 
form a unidimensional scale in some patient groups (16, 17), 
and showed that not all PF10 items function similarly across 
diagnostic groups (17, 19). These contradictory results may be 
due to differences in the type of patient groups or countries. 
It is therefore not clear in which patient groups the PF10 can 
be used and whether the results of the PF10 can be pooled or 
compared between different neurological patient groups. 
The aims of this study were: (i) to investigate the unidimen-
sionality of the PF10 in patients with stroke, multiple sclerosis 
(MS) and amyotrophic lateral sclerosis (ALS), within the 
groups; and (ii) to investigate DIF across the groups.
METHODS
Subjects and design
This investigation was performed as part of a 3-year follow-up study 
on the functional prognosis of patients with neurological disorders. The 
SF-36 scores at 6 months after inclusion were used for the analyses of 
this study. Three patient groups with different neurological disorders 
were investigated: (i) patients with a first-ever supratentorial stroke, 
who had been admitted for inpatient rehabilitation, but had left the 
rehabilitation centre at the time of measurement (6 months post-stroke), 
(ii) patients with recently diagnosed MS, 6–12 months after diagnosis, 
and (iii) patients with probable or definite ALS, according to the re-
vised El Escorial (20) criteria, who were attending a outpatient clinic 
of an university hospital (department of neurology or rehabilitation 
medicine), with a disease duration from onset of symptoms ranging 
from 6 months to 5 years (average 1.5 years). 
Physical Functioning scale of the SF-36
The PF10 is 1 of the 8 sub-scales of the SF-36, each of which measures 
a different construct of health-related quality of life. This self-reported 
health status measurement instrument was developed in the USA with 
data from the Medical Outcome Study (1). The PF10 consists of 10 
items that assess the extent of health-related limitations in physical 
functioning. Its reliability and validity have been supported in previous 
studies (3, 4). The items are scored on a 3-point Likert scale (1 = li-
mited a lot, 2 = limited a little, 3 = not limited at all). The scale was 
designed to be applicable to general populations as well as patients 
with acute and chronic diseases.
Fit with the Rasch model
Rasch analysis was applied to investigate the unidimensionality of the 
PF10 scale within the 3 patient groups, and to investigate DIF between 
the groups. If the data fit the Rasch model, item scores can be used to 
determine item difficulty and person ability on a common interval scale. 
Person ability and item difficulty are expressed in log-odd units (logits). 
The Rasch model assumes that easier items are more likely to be pass-
ed, and that less disabled persons are more likely to pass an item than 
more disabled persons. For this analysis we used the Rasch partial credit 
model, which allows the intervals between the thresholds of the answer 
categories (point of equal probability between 2 adjacent categories) 
to vary between items. Fit of the items with the model is investigated 
by examining the fit residuals and χ2 statistics (21). The standardized 
fit residuals of the responses of all persons to the item (distributed as 
a Z statistic with a mean of 0 and a standard deviation (SD) of 1 for 
perfect fit with the model) indicate the deviation of the observed item 
score from the model-expected scores. High fit residuals (> 2.5) indicate 
that the observed scores are higher or lower than the model expected 
values. Low fit residuals (< –2.5) indicate that items are redundant 
(21). The χ2 item-trait interaction statistic was applied to investigate 
whether the fit with the model was satisfactory along the whole scale 
(invariance of the scale at different levels of ability). To investigate 
this, the group was sub-divided, based on level of ability, into different 
class intervals of approximately the same number of patients along the 
trait, with around 50–60 patients in each class interval. Non-significant 
χ2 statistics indicate that items fit the model at all levels of ability (21). 
The level of significance was adjusted by the Bonferroni procedure for 
multiple testing (p = 0.005). The χ2 statistics were calculated for each 
item individually, and for the overall scale (sum of the item χ2). If all 
items fit the Rasch model, an additional principal component analysis of 
the residuals is required to support unidimensionality. The first residual 
component should account for less than 40% of the variance to support 
unidimensionality of the scale (21). Analyses were performed with the 
RUMM2020 software package (21).
Rasch analysis within each patient group: unidimensionality
We first investigated whether the scale fulfilled the criteria for uni-
dimensionality in each separate group (research question one). We 
investigated whether individual items fitted the Rasch model, by 
examining the fit residuals and χ2 statistics, as described above. Non-
fitting items were removed until an overall fitting model (indicated by 
a non-significant overall χ2) was achieved for each group. This was 
followed by a principal component analysis for each separate group.
Rasch analysis for the total group: differential item functioning
Subsequently, to investigate whether items functioned similarly across 
patient groups, DIF was investigated by performing a Rasch analysis 
on the total group (3 patient groups combined). Because items have 
to fit the Rasch model before DIF can be investigated, non-fitting 
items were first removed. DIF was investigated in all remaining fitting 
items by performing a two-way analysis of variance (ANOVA) of the 
residuals, using patient group (stroke, MS, ALS) and class interval 
(ability groups, as described above) as factors (21). DIF was identified 
by a significant ANOVA main effect of patient group (i.e. a constant 
difference between groups: uniform DIF) or an ANOVA interaction 
effect of group and class interval (i.e. the difference between groups 
varied across the trait: non-uniform DIF) (21). 
To make group comparisons possible, we adjusted for DIF by 
sub-dividing items that showed DIF, into 2 or 3 group-specific items, 
as described by Tennant et al. (13). The final overall analysis was 
performed with the items that showed no DIF, combined with the 
group-specific items for the items that showed DIF. Again, non-fitting 
items were removed until a fitting model was achieved. 
The PF10 Rasch estimates for person ability were transformed to a 
score from 0 to 100. Mean patient group values were calculated using 
the adjusted PF10 estimates (with the split DIF items) and using the 
PF10 estimates without adjustments (no split items). To determine the 
effect of the adjustment procedure, an ANOVA for repeated measures 
was performed, with adjusted vs non-adjusted as within-subject factor, 
and patient group as between subject-factor.
RESULTS
Subjects
The subjects comprised: 198 patients with stroke, 151 patients 
with MS and 194 patients with ALS. The mean age (SD) was 
57.3 (11.8), 38.4 (9.8) and 57.9 (10.8) years, and the percentage 
of females was 39%, 63% and 32% for patients with stroke, 
MS and ALS, respectively. 
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In the stroke group, 116 (59%) patients had left hemisphere 
lesions, 80 patients (40%) had right hemisphere lesions and 2 
(1%) had bilateral lesions. A total of 147 (74%) of the patients 
had a cerebral infarction, and 50 (25%) patients had a hemorrha-
gic stroke, 17 of whom had a subarachnoid haemorrhage. For 
one patient the type of lesion was unknown. For 28 patients 
who had signs of aphasia, the SF-36 was completed by intervie-
wing proxies (relatives). To investigate the effect of including 
the 28 proxies, we performed the analysis with and without 
proxies, but the results remained the same. It was therefore 
decided to include these patients in the study. 
In the MS group, 115 (76%) patients had relapsing-remitt-
ing MS, 22 (15%) had primary-progressive MS, 8 (5%) had 
secondary-progressive MS. For 6 (4%) patients the type of MS 
could not be determined at the time of diagnosis. 
In the ALS group 42 (22%) patients had a bulbar onset of 
the disease, and 150 (77%) had a spinal onset. For one (1%) 
patient the onset was unknown.
Missing values were treated as described in the SF-36 
manual (22) (the mean value of the non-missing items was used 
to calculate sub-scale scores if 50% or more of the sub-scale 
items were not missing). Following this procedure, one subject 
in the ALS group was excluded because of missing items. The 
mean raw PF10 scores, as well as the floor and ceiling effects 
for each group are shown in Table I. Except for the ceiling 
effect of 15% for the MS group, all the other floor/ceiling 
effects were negligible.
Rasch analysis within each group: unidimensionality
Item difficulties and fit residuals for each patient group are 
shown in Table II. The item difficulties are expressed on an 
interval scale in logits. Because the PF10 items have 3 answer 
categories, the item difficulty is the mean of the 2 thresholds 
(the point of equal probability between 2 adjacent answer 
categories). The answer categories showed no disordered 
Table I. Descriptive 10-item Physical Functioning (PF) sub-scale
Stroke
n = 198
MS
n = 151
ALS
n = 193
Floor (%) 0.5 0.7 11.9
Ceiling (%) 3.5 15.2 2.6
PF10 Raw score (mean (SD)) 58.4 (25.4) 69.0 (26.8) 40.5 (31.4)
PF10 Rasch estimates (no adjustment for DIF) (mean (SD)) 50.4 (19.8) 60.8 (24.4) 38.0 (25.5)
PF10 Rasch estimates with adjustment for DIF (split items) (mean (SD)) 49.7 (19.6) 55.1 (22.2) 33.9 (23.5)
MS: multiple sclerosis; ALS: amyotrophic lateral sclerosis; SD: standard deviation; DIF: differential item functioning.
Table II. Difficulty and fit of the 10-item Physical Functioning (PF) sub-scale items for each patient group analysed separately
Stroke MS ALS
Item
Lo-
cation SE
Fit re-
sidual χ2
p-
value*
Lo-
cation SE
Fit re-
sidual χ2
p-
value*
Lo-
cation SE
Fit re-
sidual χ2
p-
value*
PF1: Vigorous 
activities
4.49 0.22 –0.58 6.59 0.086 4.15 0.22 2.45 0.83 0.661 3.21 0.22 –1.47 3.38 0.184
PF2: Moderate 
activities
1.14 0.15 0.36 0.92 0.820 0.32 0.21 –0.53 0.59 0.744 0.25 0.16 –1.44 0.94 0.626
PF3: Lifting/
carrying groceries
1.14 0.14 –0.59 4.05 0.256 –0.16 0.21 –1.94 4.66 0.097 0.25 0.16 –0.12 0.18 0.912
PF4: Climbing 
several flights of 
stairs
–0.65 0.15 –1.29 2.48 0.479 0.81 0.20 –0.61 0.91 0.636 0.04 0.16 –1.47 3.12 0.210
PF5: Climbing 1 
flight of stairs
–1.68 0.16 –0.56 1.61 0.657 –1.65 0.23 –1.00 2.93 0.231 –1.13 0.17 –1.71 1.64 0.441
PF6: Bending/
kneeling/stooping
0.06 0.14 2.41 13.70 0.003 –0.22 0.20 2.51 9.98 0.007 –0.30 0.16 0.30 1.66 0.437
PF7: Walking more 
than 1 km 
0.78 0.13 –0.66 1.10 0.776 1.30 0.19 –0.99 4.20 0.123 0.86 0.16 –1.47 4.62 0.099
PF8: Walking 
several 100 m
–0.68 0.14 –2.43 10.63 0.014 –0.82 0.21 –2.15 1.76 0.416 –0.49 0.16 –2.44 5.05 0.080
PF9: Walking 100 m –1.93 0.17 –1.44 5.52 0.138 –1.54 0.21 –1.60 0.86 0.652 –1.57 0.16 –1.13 1.66 0.435
PF10: Bathing/
dressing
–2.67 0.18 0.01 2.38 0.498 –2.19 0.23 –0.30 0.96 0.619 –1.13 0.16 4.37 23.57 0.000
Total – – – 48.98 0.016 – – – 27.66 0.118 – – – 45.83 0.001
*Adjusted p-value of 0.005 was applied; misfit in bold type.
MS: multiple sclerosis; ALS: amyotrophic lateral sclerosis; SE: standard error.
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thresholds for any of the items, indicating that the difficulty 
of the answer categories was as expected. 
In the stroke and the MS groups, all items fitted the Rasch 
model. In the stroke group, the item “Bending, kneeling, stoop-
ing” (item 6) showed a borderline χ2 value (13.7, p = 0.003). 
However, because the fit residual of this item was within 
the accepted range (2.4), and the overall fit of the scale was 
acceptable (χ2 = 48.98, p = 0.016), we did not remove this 
item from the scale. In the MS group, all 10 items fitted the 
model (overall χ2 = 27.66, p = 0.118). In the ALS group, the 
item “bathing and dressing” (item 10) showed considerable 
misfit for both fit residual (4.37) and the χ2 statistic (23.57, 
p < 0.001, Table II). After removing this item from the scale, 
the remaining 9 items in the ALS group all fitted the model, 
showing a good overall scale fit (χ2 = 17.24, p = 0.507). Prin-
cipal component analysis of the residuals showed that the first 
residual component accounted for only 22%, 20% and 27% of 
the variance in the stroke, MS and ALS groups, respectively, 
supporting unidimensionality. 
Rasch analysis for the total group: differential item functioning
Initial analysis of the 3 groups combined showed that two items 
(item 6: “bending, kneeling, stooping” and item 10: “bathing 
and dressing”) had fit residuals exceeding 2.5, and two other 
items (item 8: “walking several hundred metres” and item 9: 
“walking 100 metres”) had fit residuals of less than –2.5. Items 
8 and 10 also had significant χ2 item-trait interaction statistics 
(Table III), indicating that the fit of the model was not the same 
for the different levels of ability (class intervals). All 10 items 
showed ordered thresholds between answer categories. 
First, the 2 most misfitting items (items 8 and 10) were 
subdivided into group-specific items, and the analysis was 
repeated. All 3 group-specific items of item 8 showed large fit 
residuals and were therefore removed from the total sample for 
all groups. For ALS, item 10 showed a very large fit residual 
(4.35), while the fit residual and χ2 statistic of item 10 for stroke 
and MS were within the acceptable range. Therefore, item 10 
for ALS was removed from the sample. After repeating the 
analysis with the remaining items, all items fitted the model 
(both fit residuals and χ2 statistics). 
DIF was then investigated in the remaining items. The item 
showing the most serious DIF was first adjusted by defining 
2 or 3 group-specific items, and then repeating the analysis. 
This procedure was followed until all items were free of DIF 
and fitted the model. Finally, 4 items (items 5, 7, 9, and item 
10 for stroke and MS only) showed no DIF. Five items (items 
1, 2, 3, 4 and 6) showed DIF between the stroke group and the 
MS and ALS groups. For these items, the stroke group-specific 
items were included in the final analysis. No DIF was found 
between the MS and the ALS group. In the final analysis, 
including split items (stroke vs ALS/MS) for items 1, 2, 3, 4 
and 6, the fit residuals ranged from –1.75 to 2.29, and the χ2 
statistics were all non-significant, with a non-significant overall 
scale χ2 (51.48, p = 0.15) (Table IV). Unidimensionality of the 
scale was supported by principal component analysis of the fit 
residuals, showing that the first residual component accounted 
for only 19% of the variance. The final item difficulties for 
each group are shown in Fig. 1. 
Mean PF10 person abilities for values calculated with and 
without adjusting for DIF by splitting the DIF items are shown 
Table III. Difficulty and fit of the 10-item Physical Functioning (PF) sub-scale items for the total group
Item Location SE Fit residual χ2 p-value*
PF1: Vigorous activities 3.73 0.12 0.42 9.78 0.201
PF2: Moderate activities 0.61 0.10 –0.91 6.66 0.465
PF3: Lifting/carrying groceries 0.54 0.09 –0.67 20.66 0.004
PF4: Climbing several flights of stairs –0.09 0.09 –0.91 11.10 0.134
PF5: Climbing one flight of stairs –1.48 0.10 –1.75 10.77 0.149
PF6: Bending/kneeling/stooping –0.13 0.09 2.62 6.06 0.533
PF7: Walking more than one km 0.90 0.09 –1.81 9.16 0.241
PF8: Walking several hundred metres –0.64 0.09 –4.61 30.23 0.000
PF9: Walking 100 metres –1.69 0.10 –2.73 20.03 0.005
PF10: Bathing/dressing –1.77 0.10 2.90 33.55 0.000
Total – – – 157.99 0.000
*Adjusted p-value of 0.005 was applied; misfit in bold type.
SE: standard error.
Table IV. 10-item Physical Functioning (PF) sub-scale adjusted for 
differential item functioning by diagnosis (with split items)
Item Location SE
Fit 
residual χ2 p-value
PF10 MS/stroke –2.70 0.14 –0.39 2.15 0.542
PF9 –2.15 0.10 –1.55 5.91 0.116
PF5 –1.99 0.10 –1.75 5.71 0.127
PF6 MS/ALS –0.85 0.12 1.64 3.13 0.373
PF4 stroke –0.85 0.15 –1.44 3.22 0.359
PF3 MS/ALS –0.51 0.13 –1.13 1.99 0.574
PF2 MS/ALS –0.32 0.13 –1.09 1.49 0.686
PF4 MS/ALS –0.23 0.13 –1.59 4.20 0.241
PF6 stroke –0.13 0.14 2.29 10.29 0.016
PF7 0.50 0.09 –0.97 1.34 0.719
PF3 stroke 0.95 0.14 –0.55 5.29 0.152
PF2 stroke 0.96 0.15 0.22 1.68 0.641
PF1 MS/ALS 2.98 0.15 0.68 0.72 0.869
PF1 stroke 4.33 0.22 –0.56 4.38 0.224
MS: multiple sclerosis; ALS: amyotrophic lateral sclerosis; 
SE: standard error.
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in Table I. There was a significant ANOVA interaction effect 
of adjustment (yes or no) and group (F = 388.7, p < 0.001), 
indicating that the adjustment procedure affected the differen-
ces between groups.
DISCUSSION
The objective of this study was to investigate the unidimen-
sionality of the PF10 scale in patients with stroke, MS and 
ALS, and to determine whether PF10 scores can be compared 
between groups or pooled for combined analysis. The results 
showed that, with the exception of item 10 in the ALS group, 
the PF10 items form a unidimensional scale within each patient 
group, which confirms that the items measure one underlying 
construct and that the summation of individual item scores 
to create a total score is justified in patients with stroke and 
MS, and, with exception of item 10, also in ALS patients. The 
results also demonstrated that some items showed DIF for 
the stroke group vs the MS and ALS groups, indicating that 
adjustments for DIF are necessary when pooling or comparing 
data between these groups. 
Unidimensionality 
Scaling assumptions of the PF10 of the SF-36 have been exten-
sively investigated, using methods based on the classical test 
theory, such as Cronbach’s alphas, item-scale correlations and 
factor analysis, all showing excellent internal consistency and 
high item-scale correlations across different patient groups and 
countries (3, 4, 23–26). Other studies that have investigated 
unidimensionality with the more stringent Rasch model showed 
that some items did not fit the Rasch model (5, 18, 19), but 
nevertheless concluded that unidimensionality was supported, 
because the proportion of subjects with unexpected responses 
(and thus causing misfit of these items) was sufficiently low 
(< 5%) (5). Others concluded that unidimensionality could 
not be supported because of some misfitting items (16, 17). 
In contrast, our results showed that, except for one item in 
the ALS group, all items fitted the Rasch model within the 
groups, indicating that the items form a unidimensional scale. 
The larger number of items showing misfit in earlier studies 
(5, 16–18) may be due to differences in group characteristics 
(different patient groups or a healthy population). Another 
possible explanation is that we used the more flexible partial 
credit model that allows for variations between items in the 
threshold levels of adjacent categories, while most previous 
studies used the Rasch rating scale model (5, 17, 18). 
The large misfit for item 10 in the ALS group was in agree-
ment with Jenkinson et al. (17). Other studies also reported 
large fit residuals for item 10 in other patient groups (5, 16, 
17), including patients with stroke (19), and in the general 
population across several countries (18). This misfit may be 
due to the fact that this item measures more than one activity 
(i.e. bathing or dressing). The good fit for all items of the 
MS group is in agreement with 2 former studies, using Rasch 
analysis (19) and a non-parametric item response theory 
model (Mokken analysis) (27) both reporting that the PF10 
is a strong unidimensional, hierarchical scale. The negative 
misfit of item 8 (“walking several hundred metres”) in the 
total group may be explained by a large interdependency of 
this item with other items. 
Our results showed that, in accordance with the original 
scale in several diagnostic groups (5), and in the general Dutch 
population (18), item 1 was the most difficult, and items 9 
and 10 were the easiest. The intermediate items showed more 
variation in item hierarchy, when compared with US patients 
with several chronic conditions (5), than when compared with 
the general (Dutch) population (18). Comparison with the latter 
study showed that item 7 (“walking more than one mile”) was 
more difficult in our study (rank 2) than in Dutch healthy pers-
ons (rank 6) (18). It was also found that the interval between 
the most difficult item (item 1) and the adjacent item (item 2) 
is much larger than the item intervals in the mid-range. This 
finding is consistent with the results of previous studies (5, 18, 
28, 29), and leads to an underestimation of change in physical 
functioning score (less numerical gain) at the high end of the 
score distribution when using the raw ordinal PF10 scores 
(29). It has been argued that, because of the unequal intervals 
between raw item scores, a Rasch-based score would improve 
discrimination and sensitivity to change in the PF10 scale (18, 
28, 29). This should be further investigated in patients with 
stroke, MS and ALS. 
Differential item functioning
The results show that there were differences in item difficulty 
between stroke patients, and patients with MS or ALS. More 
specifically, 4 out of the 9 fitting PF10 items were more dif-
ficult for stroke patients, and 1 item was easier than for MS 
and ALS patients, while for MS and ALS patients all items 
demonstrated similar characteristics. For example, item 3 
(“lifting/carrying groceries”) was more difficult for patients 
Fig. 1. Difficulties (expressed in logits) of 10-item Physical Functioning 
sub-scale (PF10) items for patients with stroke, multiple sclerosis (MS) 
and amyotrophic lateral sclerosis (ALS) after a combined Rasch analysis. 
Note that items 8 and 10 (for ALS only) have been removed.
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with stroke than for patients with MS and ALS. This may be 
clinically explained by the unilateral impairment of the arms 
of stroke patients. These results suggest that caution should be 
taken when comparing the results of the PF10 scale between 
stroke patients and the other patient groups, or when pooling 
the data in a single analysis. 
We used a method to adjust for DIF, described by Tennant 
et al. (13), that allows pooling of the data of different (patient) 
groups when DIF is present. However, in order to apply this 
method, some common items (that do not show DIF) are requir-
ed. In our study, 3 items (5, 7 and 9) showed no DIF between 
groups, so these could be used to link the groups (13). In the 
pooled analysis we had to delete the ALS group-specific item 
10, and also item 8 because the fit residuals were too large. The 
other items, including the 5 stroke-specific items, were used 
to describe the physical functioning of the 3 patient groups on 
one common measurement continuum, and can therefore used 
to compare physical functioning between the groups.
Our results differed from the results of an earlier study 
investigating the item response patterns in different patient 
groups by applying Rasch analysis (5). The authors conclud-
ed that the item structure was reproducible across patient 
groups, but they nonetheless also reported large differences 
in item difficulty between the groups. Another study investi-
gating differences in item responses between MS patients and 
patients with other chronic diseases using Mokken analysis, 
reported no differences in item hierarchy (27). In contrast, 
Jenkinson et al. (17) and Bode et al. (19) reported results that 
were comparable to the results of the present study, showing 
differences in item difficulty between patients with ALS or 
MS and other diseases. These results confirm that differences 
in item difficulty do exist between patient groups, and should 
be investigated before comparing PF10 data. In addition, our 
results showed that group differences are influenced by the 
adjustments for DIF, indicating that adjustments for DIF are 
required when comparing stroke with ALS or MS.
It is concluded that the PF10 is a useful scale for measuring 
physical functioning in patients with neurological disorders 
during rehabilitation. The results also indicate that it is not 
appropriate to compare or combine the PF10 scale of patients 
after stroke with that of patients with MS and ALS without 
adjusting for DIF. However, the PF10 data of patients with MS 
and ALS can be compared without adjustments.
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